Balancing Act of the Intestinal Antimicrobial Proteins on Gut Microbiota and Health

DOI: https://doi.org/10.1007/s12275-024-00122-3
2024-04-18
The Journal of Microbiology
Abstract:The human gut houses a diverse and dynamic microbiome critical for digestion, metabolism, and immune development, exerting profound effects on human health. However, these microorganisms pose a potential threat by breaching the gut barrier, entering host tissues, and triggering infections, uncontrolled inflammation, and even sepsis. The intestinal epithelial cells form the primary defense, acting as a frontline barrier against microbial invasion. Antimicrobial proteins (AMPs), produced by these cells, serve as innate immune effectors that regulate the gut microbiome by directly killing or inhibiting microbes. Abnormal AMP production, whether insufficient or excessive, can disturb the microbiome equilibrium, contributing to various intestinal diseases. This review delves into the complex interactions between AMPs and the gut microbiota and sheds light on the role of AMPs in governing host-microbiota interactions. We discuss the function and mechanisms of action of AMPs, their regulation by the gut microbiota, microbial evasion strategies, and the consequences of AMP dysregulation in disease. Understanding these complex interactions between AMPs and the gut microbiota is crucial for developing strategies to enhance immune responses and combat infections within the gut microbiota. Ongoing research continues to uncover novel aspects of this intricate relationship, deepening our understanding of the factors shaping gut health. This knowledge has the potential to revolutionize therapeutic interventions, offering enhanced treatments for a wide range of gut-related diseases.
microbiology
What problem does this paper attempt to address?
The paper primarily explores the complex interactions between antimicrobial peptides (AMPs) and the gut microbiota, emphasizing the crucial role of AMPs in regulating the host-microbiota relationship. Specifically, the paper focuses on the following aspects: 1. **Importance of the Gut Microbiota**: The gut contains a large community of microorganisms that play a key role in digestion, metabolism, and the development of the immune system. However, these microorganisms can also cause infections, inflammation, and even sepsis. 2. **Role of Intestinal Epithelial Cells**: Intestinal epithelial cells form the first line of defense against microbial invasion. The antimicrobial peptides (AMPs) produced by these cells regulate the gut microbiota by directly killing or inhibiting microorganisms. 3. **Regulatory Mechanisms of AMPs**: Abnormal production of AMPs (whether excessive or insufficient) can disrupt the balance of the microbiota, leading to various intestinal diseases. Therefore, understanding the regulatory mechanisms of AMPs and their relationship with the gut microbiota is crucial for developing new therapeutic strategies. 4. **Functions and Mechanisms of AMPs**: The paper details the characteristics and antimicrobial mechanisms of different types of AMPs (such as defensins, cathelicidins, lysozymes, etc.) and discusses how they indirectly affect the microbiota through immune modulation, spatial segregation, and resource limitation. 5. **Microbial Evasion Strategies**: To resist the effects of AMPs, microorganisms adopt various strategies, including producing proteases, altering cell membrane structures, and enhancing the expression of efflux pumps. By deeply studying the interactions between AMPs and the gut microbiota, the paper aims to provide a theoretical foundation for designing new therapies to enhance immune responses and combat intestinal infections in the future.